Corcept Therapeutics (CORT) Total Debt (2012 - 2023)

Corcept Therapeutics (CORT) reported Total Debt of $14.0 million for Q4 2023, little changed on a YoY basis from $14.0 million in Q4 2022, and little changed sequentially from $14.0 million in Q3 2023.

Corcept Therapeutics (CORT) Total Debt (2012 - 2023) Analysis & Trends

Corcept Therapeutics (CORT) has 8 years of Total Debt data on file, last reported at $14.0 million in Q4 2023.

  • For the quarter ending Q4 2023, Total Debt changed 0.0% year-over-year to $14.0 million; the trailing twelve-month figure through Dec 2023 stood at $14.0 million (changed 0.0% YoY), and the FY2023 full-year result was $14.0 million, changed 0.0% from the prior year.
  • Total Debt steadied at $14.0 million in Q4 2023, from $14.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $14.0 million in Q4 2022 to a low of $14.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 110.96 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 959.06 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Corcept Therapeutics 9.99 Bn 9.65 Bn 162.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 14.00 Mn
Sep 30, 2023 14.00 Mn
Jun 30, 2023 14.00 Mn
Mar 31, 2023 14.00 Mn
Dec 31, 2022 14.00 Mn
Jun 30, 2017 4.57 Mn
Mar 31, 2017 10.11 Mn
Dec 31, 2016 14.66 Mn
Sep 30, 2016 18.73 Mn
Jun 30, 2016 22.30 Mn
Mar 31, 2016 25.04 Mn
Dec 31, 2015 27.49 Mn
Sep 30, 2015 29.64 Mn
Jun 30, 2015 31.43 Mn
Mar 31, 2015 32.78 Mn
Dec 31, 2014 33.89 Mn
Sep 30, 2014 34.65 Mn
Jun 30, 2014 35.03 Mn
Mar 31, 2014 35.11 Mn
Dec 31, 2013 35.07 Mn